With this U.S. patent now granted and providing protection into 2042, we have established an important long-term intellectual property foundation for stenoparib and our DRP® companion diagnostic,” ...
InflaRx intends to engage with EMA regarding both vilobelimab and izicopan to evaluate the regulatory path to approval in ANCA-associated ...
DSpark can make decoding faster, but acceptance quality still determines how much speed the system actually realizes.
The proposal is the latest attempt to complete Atlantic Yards, a project near Downtown Brooklyn that includes building ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results